Back
Y-mAbs Therapeutics Stock Predictions
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
40
YMAB
Y-mAbs Therapeutics
Last Price:
$4.68
Seasonality Move:
9.23%
7 Day Trial
ALL ACCESS PASS
$
7
Could BOXABL Be the Tesla of Housing?
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Y-mAbs Therapeutics Stock Forecast
-
Is Y-mAbs Therapeutics Stock Undervalued?The current Y-mAbs Therapeutics [YMAB] share price is $4.41. The Score for YMAB is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
YMAB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Y-mAbs Therapeutics Stock Go Up Next Year?
Data Unavailable
Y-mAbs Therapeutics Stock Rating
Data Unavailable
Y-mAbs Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ymabs.com
52-Week Data
52-Week High:
16.11
52-Week Low:
3.55
Prediction Charts
Market Cap:
199.7M
Price in USD:
4.41
Volume:
181.6K
Beta:
0.82
Technical Analysis
SMA50:
4.42
SMA100:
5.29
SMA200:
8.97
52-Wk Change:
-63.91%
Stock Predictions
-
Is Y-mAbs Therapeutics stock public?Yes, Y-mAbs Therapeutics is a publicly traded company.
-
What is the Y-mAbs Therapeutics stock quote today?The Y-mAbs Therapeutics stock price is 4.41 USD today.
-
How to buy Y-mAbs Therapeutics stock online?You can buy Y-mAbs Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-7 | 3.91 | 3.88 | 4.03 | 3.83 |
| May-8 | 3.87 | 4.04 | 4.07 | 3.76 |
| May-9 | 4.06 | 3.89 | 4.26 | 3.87 |
| May-12 | 4.06 | 4.07 | 4.18 | 3.94 |
| May-13 | 4.48 | 4.16 | 5.04 | 4.06 |
| May-14 | 4.11 | 3.64 | 4.31 | 3.63 |
| May-15 | 3.64 | 3.86 | 3.88 | 3.55 |
| May-16 | 3.86 | 4.10 | 4.12 | 3.82 |
| May-19 | 4.03 | 4.17 | 4.27 | 4.03 |
| May-20 | 4.14 | 4.23 | 4.31 | 4.13 |
| May-21 | 4.15 | 4.10 | 4.23 | 4.07 |
| May-22 | 4.08 | 4.13 | 4.18 | 3.99 |
| May-23 | 4.01 | 4.32 | 4.33 | 4.00 |
| May-27 | 4.39 | 4.41 | 4.45 | 4.22 |
Y-mAbs Therapeutics Earnings
Data Unavailable
Y-mAbs Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.09 per share.
* Y-mAbs Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.